Recent News - Cannabis
June 10, 2022 |
Marc Ullman spoke with Natural Products INSIDER for the article, “FDA hoping to shrink pool of noncompliant ingredient notifications.”
The story discusses the U.S. Food & Drug Administration’s recent guidance that it is providing a 180-day amnesty to manufacturers of nutritional products that failed to file a New Dietary Ingredient (NDI) notification.
Marc is not convincedRead More
May 16, 2022 |
Ullman was cited in the Natural Products Insider article “Lawyers skeptical FDA warning letters will chill delta-8 THC market.”
The article discusses the effect of the recent rash of FDA warning letters on delta-8 THC products. The warning letters note that delta-8 THC is not an approved treatment for medical conditions.
Asked whether the warningRead More
April 26, 2022 | |
Marc Ullman was quoted in the Natural Products Insider article, “FDA written enforcement discretion on CBD unlikely.”
The article discusses how the FDA is unlikely to issue a formal policy of enforcement discretion for CBD-containing products marketed as dietary supplements.
Ullman doesn’t believe the agency would issue a CBD enforcement discretion policy similar to NAC.Read More
August 30, 2021 | |
In the Long Island Business News article, “To: Gov. Kathy Hochul, From: Long Island, Re: Wish list,” several Long Island business leaders offered their perspective on the issues New York’s newest governor should focus on first.
Louis Vlahos provided a business-friendly agenda:
- Eliminate the stock transfer tax
- Eliminate NYC’s commercial rent tax
- Reduce the personal
July 22, 2021 | |
On July 21, 2021, Tamika Hardy spoke at the Employment & NY Marijuana Legalization (MRTA) panel, presented by the Brooklyn branch of the NAACP.
The Brooklyn NAACP’s Justice Reform and Legal Redress Committees discussed the New York legalization of cannabis as it relates to employment.
Hardy discussed what recreational cannabis legalization means in the employmentRead More
April 8, 2021 |
Rivkin Radler LLP is pleased to announce that Louis Vlahos placed No. 2 among the top 10 authors on the topic of tax law for 2021 in JD Supra’s Readers’ Choice Awards. Lou is a partner in the firm’s Business Dissolution; Cannabis; Corporate; Personal, Family & Business Planning; and Tax practice groups.
This year’s Readers’Read More
March 29, 2021 | |
Steven Shapiro was quoted in the Vitamin Retailer article, “FDA Warns Selling of Topical CBD Products Violates FD&C Act.”
The FDA has issued warning letters to two companies addressing the illegal marketing of unapproved drugs labeled as containing CBD.
Shapiro questions the letters as neither discussed the potential to use CBD as an inactive ingredientRead More
March 9, 2021 |
Marc Ullman will be a speaker at the Dietary Supplement Good Manufacturing Practices (GMP) Compliance Virtual Seminar.
The event will be held on May 3, 5, 10 & 12, 2021.
In these unprecedented times, the dietary supplement industry is playing an essential role for the U.S. consumer. Never before have more questions been raised regardingRead More
January 20, 2021 |
Greg Miller, Nancy Del Pizzo and J’Naia Boyd overcame a motion for reconsideration of a federal magistrate judge’s report and recommendations where defendants had sought compensation from our clients in the six figures in this trademark action. Our Intellectual Property team convinced the district judge that the case is not “exceptional” under the Lanham Act,Read More
January 13, 2021 |
Marc Ullman will be a panelist at the Dietary Supplement Good Manufacturing Practices (GMP) Compliance Virtual Seminar.
The seminar will be held on February 2, 4, 9 and 11 from 11:00am to 4:00pm.
In these unprecedented times, the dietary supplement industry is playing an essential role for the U.S. consumer. Never before have more questionsRead More
- Business Dissolution
- Commercial Litigation
- Complex Torts & Product Liability
- Compliance Investigations & White Collar
- Directors & Officers Liability
- Diversity & Inclusion
- Employment & Labor
- General Liability
- Health Services
- Insurance Coverage
- Insurance Fraud
- Intellectual Property
- Medical Malpractice Defense
- Privacy, Data & Cyber Law
- Professional Liability
- Real Estate, Zoning & Land Use
- Trusts & Estates